Recent News
Our CEO, Dr. Fan was invited to present in SAPA-GP(Sino-American Pharmaceutical Professionals Association - Greater Philadelphia) Annual Conference...
Accutar’s side chain flexible docking platform assisted discovery of bisubstrate inhibitors of Nicotinamide N-Methyltransferase (NNMT)
Dr. Fan, presented Accutar’s proprietary deep neural network framework in AI in drug discovery congress, London
Ligand docking and virtual screen for drug discovery
A video demonstrates how Orbital docking and virtual screen works.
ADME prediction aids drug development
A dynamic deep neural network specifically designed for cheminformatics.
LEADERSHIP
Jie Fan, Ph.D.
Founder and CEO
Dr. Fan was trained at UC, Berkeley in Biostatistics and obtained his Doctor degree from Cornell/Sloan-kettering in structural
biology/Immunology. He was further trained by Dr. Gunter Blobel at Rockefeller University. With a dream of using
a hybrid approach (by combining computation design and experimental validation) to accelerate drug discovery,
and to reform current “hit-2-lead” drug discovery scheme, Dr. Fan founded Accutar biotech with the support of
Dr. Gunter Blobel. Dr. Fan also hold a joint appointment at SUNY, Downstate medical school as a research assistant
professor.
Wei He, Ph.D.
Chief Scientific Officer
Wei He, Ph.D., brings to Accutar Biotechnology 11 years of oncology drug discovery experience in both small molecule and
biologics. Most recently, he was Associate Director of Preclinical Pharmacology at Incyte Corporation. In this
role, he oversaw cancer biology groups leading efforts of project initiation and progression to IND. Prior to
joining Incyte, Wei served as scientific project leader at Abbvie Oncology and Roche Oncology, where he led cross-functional
project teams working on immuno oncology, targeted therapy, antibody drug conjugate and therapeutic RNAi programs.
Wei obtained his B.S. and M.S. in chemistry from Peking University in China and his Ph.D. in biochemistry and molecular biology from Baylor College of Medicine. He completed his HHMI postdoctoral training at the Memorial Sloan-Kettering Cancer Center.
Wei obtained his B.S. and M.S. in chemistry from Peking University in China and his Ph.D. in biochemistry and molecular biology from Baylor College of Medicine. He completed his HHMI postdoctoral training at the Memorial Sloan-Kettering Cancer Center.
Günter Blobel, MD, Ph.D.
Rockefeller University
Dr. Blobel is a member of National academy of sciences and is recognized by numerous awards including Nobel Prize in physiology
and medicine (1999) and Albert Lasker Award for Basic Medical Research (1993). He served as selection committee
member for prestigious Lasker award, Shaw prize and Wiley prize etc. He also sits on board of directors for Nestle
and Board of Scientific Governors at The Scripps Research Institute.
Jerard Hurwitz, Ph.D.
Memorial Sloan-kettering Institute
Dr. Hurwitz is a member of the National Academy of Sciences and the American Academy of Arts and Sciences. His notable awards
include: the Eli Lilly Award in Biological Chemistry, the Institut Pasteur Hazen Lectureship, and the New York
Academy of Science's Louis and Bert Freeman Foundation Prize for Research in Biochemistry.
Jian Jin, Ph.D.
Icahn School of Medicine at Mount Sinai
Dr. Jin is a Professor of Structural & Chemical Biology , Oncological Sciences , Pharmacology & Systems Therapeutics at Mount
Sinai. Before being recruited to Mount Sinai, Dr. Jin served as an Associate Director of medicinal chemistry
in the Center for Integrative Chemical Biology and Drug Discovery at UNC – CH from 2008 to 2014. Dr. Jin has
published more than 100 research papers and delivered 69 invited talks. He is also an inventor of 10 issued U.S.
patents and 37 published PCT patent applications.
INVESTORS
